TABLE 4.
Baseline 25(OH)D |
||||||||||
<20.0 ng/mL |
20.0–29.9 ng/mL |
≥30.0 ng/mL |
||||||||
No. of subjects | Change2 | Percentage change | No. of subjects | Change2 | Percentage change | No. of subjects | Change2 | Percentage change | P for trend4 | |
kg | % | kg | % | kg | % | |||||
Control | ||||||||||
Weight | 31 | −0.9 ± 5.2 | −0.8 ± 5.9 | 33 | −0.8 ± 5.1 | −0.9 ± 5.6 | 15 | 0.6 ± 3.2 | 0.7 ± 3.5 | 0.11 |
Body fat | 31 | 0.1 ± 3.5 | 0.6 ± 4.2 | 33 | −1.1 ± 4.2 | −0.9 ± 2.6 | 15 | 0.2 ± 2.8 | −0.1 ± 1.9 | 0.42 |
Lean mass | 31 | −0.3 ± 1.5 | 0.3 ± 2.8 | 33 | 0.4 ± 2.0 | 1.0 ± 2.4 | 15 | 0.0 ± 1.9 | −0.3 ± 2.3 | 0.06 |
Exercise | ||||||||||
Weight | 53 | −2.0 ± 3.3 | −2.2 ± 3.6 | 32 | −2.3 ± 4.8 | −2.8 ± 5.8 | 20 | −2.9 ± 4.0 | −3.4 ± 4.6 | 0.38 |
Body fat | 53 | −2.0 ± 2.7 | −1.4 ± 2.1 | 32 | −2.7 ± 4.5 | −2.2 ± 3.5 | 20 | −2.6 ± 3.6 | −1.9 ± 3.1 | 0.14 |
Lean mass | 53 | 0.3 ± 2.0 | 1.7 ± 2.2 | 32 | 0.6 ± 2.0 | 2.2 ± 3.4 | 20 | −0.1 ± 2.0 | 1.9 ± 3.3 | 0.09 |
Diet | ||||||||||
Weight | 41 | −7.0 ± 7.1 | −8.2 ± 7.7 | 48 | −9.4 ± 5.8 | −11.4 ± 7.4 | 15 | −7.3 ± 4.9 | −9.5 ± 6.2 | 0.90 |
Body fat | 41 | −6.0 ± 6.3 | −3.7 ± 4.2 | 48 | −8.0 ± 5.4 | −5.6 ± 5.2 | 15 | −6.6 ± 4.7 | −4.8 ± 4.0 | 0.12 |
Lean mass | 41 | −0.8 ± 1.5 | 3.6 ± 4.5 | 48 | −1.1 ± 1.9 | 5.4 ± 5.0 | 15 | −0.4 ± 1.6 | 4.9 ± 4.1 | 0.17 |
Diet + exercise | ||||||||||
Weight | 40 | −10.2 ± 6.2 | −11.9 ± 7.0 | 43 | −11.3 ± 7.1 | −11.3 ± 7.1 | 25 | −9.1 ± 4.1 | −11.6 ± 5.1 | 0.53 |
Body fat | 40 | −9.0 ± 5.7 | −5.6 ± 4.6 | 43 | −8.5 ± 5.6 | −6.3 ± 5.0 | 25 | −9.0 ± 3.8 | −7.3 ± 4.0 | 0.45 |
Lean mass | 40 | −1.0 ± 2.3 | 5.3 ± 4.6 | 43 | −0.5 ± 1.7 | 6.0 ± 5.0 | 25 | 0.3 ± 1.4 | 7.4 ±3.9 | 0.18 |
Analysis based on available data without imputation for missing values.
Values are arithmetic means ± SDs.
Calculated as 12-mo change (%) − baseline (%).
P for trend across serum 25(OH)D groups, adjusted for race-ethnicity (white, other), season of random assignment, and total (diet + supplement) vitamin D intake.